Socio-ethical challenges and opportunities for advancing diversity, equity, and inclusion in digital medicine
- PMID: 39372817
- PMCID: PMC11450794
- DOI: 10.1177/20552076241277705
Socio-ethical challenges and opportunities for advancing diversity, equity, and inclusion in digital medicine
Abstract
Digitalization in medicine offers a significant opportunity to transform healthcare systems by providing novel digital tools and services to guide personalized prevention, prediction, diagnosis, treatment and disease management. This transformation raises a number of novel socio-ethical considerations for individuals and society as a whole, which need to be appropriately addressed to ensure that digital medical devices (DMDs) are widely adopted and benefit all patients as well as healthcare service providers. In this narrative review, based on a broad literature search in PubMed, Web of Science, Google Scholar, we outline five core socio-ethical considerations in digital medicine that intersect with the notions of equity and digital inclusion: (i) access, use and engagement with DMDs, (ii) inclusiveness in DMD clinical trials, (iii) algorithm fairness, (iv) surveillance and datafication, and (v) data privacy and trust. By integrating literature from multidisciplinary fields, including social, medical, and computer sciences, we shed light on challenges and opportunities related to the development and adoption of DMDs. We begin with an overview of the different types of DMDs, followed by in-depth discussions of five socio-ethical implications associated with their deployment. Concluding our review, we provide evidence-based multilevel recommendations aimed at fostering a more inclusive digital landscape to ensure that the development and integration of DMDs in healthcare mitigate rather than cause, maintain or exacerbate health inequities.
Keywords: AI fairness; Socio-ethical considerations; datafication, privacy and trust; digital determinants of health; digital health equity; diversity, equity and digital inclusion.
© The Author(s) 2024.
Conflict of interest statement
The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: J.K. declares an unpaid role in the European Taskforce for Harmonized Evaluation of Digital Medical Devices. A.L. has served on advisory boards with Roche (remunerated). None of the other authors report conflicts of interest.
Figures
References
-
- Strong K, Mathers C, Leeder Set al. et al. Preventing chronic diseases: how many lives can we save? Lancet 2005; 366: 1578–1582. - PubMed
-
- Elenko E, Underwood L, Zohar D. Defining digital medicine. Nat Biotechnol 2015; 33: 456–461. - PubMed
-
- The NICE Evidence Standards Framework for digital health and care technologies—Developing and maintaining an innovative evidence framework with global impact—Harriet Unsworth, Bernice Dillon, Lucie Collinson, Helen Powell, Mark Salmon, Tosin Oladapo, Lynda Ayiku, Gary Shield, Joanne Holden, Neelam Patel, Mark Campbell, Felix Greaves, Indra Joshi, John Powell, Alexia Tonnel, https://journals.sagepub.com/doi/full/10.1177/20552076211018617 (2021). - DOI - PMC - PubMed
-
- Lyles CR, Wachter RM, Sarkar U. Focusing on digital health equity. JAMA 2021; 326: 1795. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
